EXP MOL PATHOL - EXPERIMENTAL AND MOLECULAR PATHOLOGY

Publications

  1. 2022
  2. 2019
  3. High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients

    El Gammal, A. T., Melling, N., Reeh, M., Gebauer, F., Mann, O., Perez, D., Bockhorn, M., Bachmann, K., Izbicki, J. R. & Grupp, K., 04.2019, In: EXP MOL PATHOL. 107, p. 51-56 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. 2018
  5. Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancer

    Neubauer, E., Latif, M., Krause, J., Heumann, A., Armbrust, M., Luehr, C., Fraune, C., Hube-Magg, C., Kluth, M., Möller-Koop, C., Sauter, G., Simon, R., Beyer, B., Pompe, R. S., Thederan, I., Schlomm, T. & Büscheck, F., 08.2018, In: EXP MOL PATHOL. 105, 1, p. 50-56 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Expression of ICAM-1, E-cadherin, periostin and midkine in metastases of pancreatic ductal adenocarcinomas

    Grupp, K., Melling, N., Bogoevska, V., Reeh, M., Uzunoglu, F. G., El Gammal, A. T., Nentwich, M. F., Izbicki, J. R. & Bogoevski, D., 04.2018, In: EXP MOL PATHOL. 104, 2, p. 109-113 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. 2015
  8. HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

    Burdelski, C., Ruge, O. M., Melling, N., Koop, C., Simon, R., Steurer, S., Sauter, G., Kluth, M., Hube-Magg, C., Minner, S., Wittmer, C., Wilczak, W., Hinsch, A., Lebok, P., Izbicki, J. R., Heinzer, H., Graefen, M., Huland, H., Schlomm, T. & Krech, T., 18.03.2015, In: EXP MOL PATHOL. 98, 3, p. 419-426 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. 2013
  10. Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy

    Grupp, K., Höhne, T. S., Prien, K., Hube-Magg, C., Tsourlakis, M. C., Sirma, H., Pham, T., Heinzer, H., Graefen, M., Michl, U., Simon, R., Wilczak, W., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Steurer, S., 01.10.2013, In: EXP MOL PATHOL. 95, 2, p. 227-34 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer.

    Alsdorf, W. H., Clauditz, T. S., Hoenig, T., Quaas, A., Sirma, H., Koenig, A. M., Izbicki, J., Sauter, G., Marx, A. H. & Grob, T. J., 2013, In: EXP MOL PATHOL. 94, 1, p. 155-159 5 p., 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. 2010
  13. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.

    Pabst, C., Zustin, J., Jacobsen, F., Luetkens, T., Kröger, N., Schilling, G., Bokemeyer, C., Sauter, G., Atanackovic, D. & Marx, A., 2010, In: EXP MOL PATHOL. 89, 2, p. 175-181 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. 2008
  15. Oral polio vaccination leads to oligoclonal expansion of TCRBV16+ and TCRBV13+ T cells in the colon of rhesus macaques

    Hörer, S., Burdak-Rothkamm, S., Allers, K., Schneider, T. & Duchmann, R., 12.2008, In: EXP MOL PATHOL. 85, 3, p. 189-95 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review